The store will not work correctly when cookies are disabled.
9-(2-chlorobenzyl)-6-[(2-chlorobenzyl)thio]-9H-purine
ID: ALA4761066
PubChem CID: 162659169
Max Phase: Preclinical
Molecular Formula: C19H14Cl2N4S
Molecular Weight: 401.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccccc1CSc1ncnc2c1ncn2Cc1ccccc1Cl
Standard InChI: InChI=1S/C19H14Cl2N4S/c20-15-7-3-1-5-13(15)9-25-12-24-17-18(25)22-11-23-19(17)26-10-14-6-2-4-8-16(14)21/h1-8,11-12H,9-10H2
Standard InChI Key: IXXHTKHMUWVDLX-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.1836 -10.4377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1824 -11.2573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8905 -11.6662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8887 -10.0289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5973 -10.4341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6021 -11.2527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3822 -11.5012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8595 -10.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3744 -10.1767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8863 -9.2117 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.1773 -8.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4709 -9.2159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7657 -8.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0597 -9.2186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0617 -10.0367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7756 -10.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4787 -10.0306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7647 -7.9914 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.6392 -12.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4395 -12.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6913 -13.2179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4908 -13.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0350 -12.7725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7741 -11.9936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9752 -11.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1460 -13.8266 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
13 18 1 0
7 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
21 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 401.32 | Molecular Weight (Monoisotopic): 400.0316 | AlogP: 5.47 | #Rotatable Bonds: 5 |
Polar Surface Area: 43.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.00 | CX LogP: 5.70 | CX LogD: 5.70 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.33 | Np Likeness Score: -1.63 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |